The most quarterly R&D investment of Hanmi Pharmaceutical since it foundation

Published: 2014-11-05 14:57:42

Updated: 2014-11-05 15:00:01

Hanmi Pharmaceutical is advancing on development of new global drugs as it continues the biggest quarterly investment since its foundation.

Hanmi Pharmaceutical made a public announcement that it put KRW 40.1 billion, which records the highest amount of money spent in a quarter, on the development of new drugs, and the amount is estimated for a 22.4% rate against sales.

Through the R&D invest...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.